Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protocol for a Randomized, Placebo-Controlled, Double-Blinded Trial to Study the Effects of Supplementary Omega-3 Fatty Acids on Serum C-Reactive Protein Levels

NCT00578578 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT00578578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00578578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protocol for a Randomized, Placebo-Controlled, Double-Blinded Trial to Study the Effects of Supplementary Omega-3 Fatty Acids on Serum C-Reactive Protein Levels
Lead sponsor
The Cleveland Clinic
Phase
Phase 4
Overall status
Terminated
Start date
September 30, 2005
Completion date
August 31, 2007
Enrollment
53 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, coronary artery disease, inflammatory response